31/05/2019 12:00:00

uniQure to Participate in Multiple Upcoming Industry Conferences

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 31, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it will participate in the following upcoming conferences in June:

  • Gordon Research Conference: CAG Triplet Repeat Disorders, June 2 – 7, Lucca (Barga), Italy.


    • Joseph Higgins, M.D., F.A.A.N., VP, clinical development, Huntington’s disease program lead, will be presenting "Silencing CAG Repeats in Huntington’s Disease and SCA3" on Friday, June 7th at 6:05 p.m. CET.


    • In addition, uniQure will be presenting in the poster session on Wednesday June 5th and Thursday June 6th: “A novel AAV-based miQURE gene therapy for SCA3” (Poster #56).

  • European Reference Network – Rare Neurological Diseases (ERN-RND) Annual Meeting, June 17 – 19, Siena, Italy. 


    • Astrid Valles-Sanchez, senior scientist biomarker research at uniQure, will be presenting “Developing microRNA-based gene therapies for Huntington Disease and Spinocerebellar Ataxia type 3” on Monday, June 17th at 3:40 p.m. CET.

  • Huntington’s Disease Society of America (HDSA) 34th Annual Convention, June 27 – 29, Boston, MA.


    • uniQure is a sponsor of the conference and will be presenting in the Boston Biotech HD Showcase session on Saturday, June 29 from 2:45 to 3:35 p.m. ET.  

About uniQure

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and other severe genetic diseases. www.uniQure.com

uniQure Contacts

For Investors:   

Maria E. Cantor  

Direct: 339-970-7536

Eva M. Mulder

Direct: +31 20 240 6103

For Media:

Tom Malone

Direct: 339-970-7558


Related content
06 Jul - 
uniQure Announces 36 Weeks of Follow-Up Data from Phase..
21 Jun - 
uniQure Announces Presentations at the Upcoming 27th Co..
22 May - 
uniQure Strengthens Intellectual Property Portfolio wit..

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg


EuroInvestor: In Focus


EuroInvestor: In Focus


EuroInvestor: In Focus

Most read news

  • 24 hours
  • 48 hours
  • 1 week
CellaVision ABs strongest quarter ever with continued growth
Corporate Social Responsibility: Eramet commits to short-term specific objectives
Yara signs new USD 1,100 million Revolving Credit Facility with margin linked to Carbon Intensity Target
Arc Aroma Pure AB: 190716 ArcAroma and Källby wastewater treatment plant starts evaluation of dynaCEPT®
Change in the Board of Directors of Realkredit Danmark A/S

Related stock quotes

Latest news

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
17 July 2019 02:16:17
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB2 - 2019-07-17 03:16:17 - 2019-07-17 02:16:17 - 1000 - Website: OKAY